Last 12 months
Inside the activity.
1 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 1 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 14, 2022 Filed Jan 19, 2022 22:45 UTC |
Hanna James KevinVP, Controller & CAO
|
GrantCommon stock, par value $0.001 | 3,332 | $0.00 | $0.00 |
DisclosureSEC source: 0001287865-22-000004 · primary_doc.xml · nonDerivative · entry 1 Hanna James Kevin · CIK 0001665881 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,761 F1 · shares: Represents additional shares earned under the 2019 performance award based on the Company's actual performance as compared to the performance hurdles defined in the award agreement. The shares vested in January 2022. Read SEC document |
| January 14, 2022 Filed Jan 19, 2022 22:22 UTC |
McLean Emmett EExecutive Vice President & COO
|
Tax withholdingCommon stock, par value $0.001 | 253,609 | $23.61 | $5,987,708.49 |
DisclosureSEC source: 0001287865-22-000003 · primary_doc.xml · nonDerivative · entry 3 McLean Emmett E · CIK 0001331446 · Executive Vice President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,788,804 F3 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the common shares vesting (pursuant to our 2019 Equity Incentive Plan) and does not represent a sale by the Reporting Person. Read SEC document |
| January 14, 2022 Filed Jan 19, 2022 22:22 UTC |
McLean Emmett EExecutive Vice President & COO
|
GrantCommon stock, par value $0.001 | 26,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001287865-22-000003 · primary_doc.xml · nonDerivative · entry 2 McLean Emmett E · CIK 0001331446 · Executive Vice President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,042,413 F2 · shares: Represents additional shares earned under the 2021 performance award based on the Company's actual performance as compared to the performance hurdles defined in the award agreement, adjusted pursuant to the modifier provisions in the award that were based on the Company's total return to shareholders. The shares vested in January 2022. Read SEC document |
| January 14, 2022 Filed Jan 19, 2022 22:22 UTC |
McLean Emmett EExecutive Vice President & COO
|
GrantCommon stock, par value $0.001 | 350,468 | $0.00 | $0.00 |
DisclosureSEC source: 0001287865-22-000003 · primary_doc.xml · nonDerivative · entry 1 McLean Emmett E · CIK 0001331446 · Executive Vice President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,016,163 F1 · shares: Represents shares earned under the 2019 performance award based on the Company's actual performance as compared to the performance hurdles defined in the award agreement along with shares earned pursuant to the modifier provisions in the award, which allowed for more shares to be earned based on how the Company's relative total return to shareholders compared to the SNL Healthcare REIT Index. The shares vested in January 2022. Read SEC document |
| January 14, 2022 Filed Jan 19, 2022 21:43 UTC |
Aldag Edward K JRDirector · Chairman, President & CEO
|
Tax withholdingCommon stock, par value $0.001 | 626,776 | $23.61 | $14,798,181.36 |
DisclosureSEC source: 0001287865-22-000001 · primary_doc.xml · nonDerivative · entry 3 Aldag Edward K JR · CIK 0001331608 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,557,980 F3 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the common shares vesting (pursuant to our 2019 Equity Incentive Plan) and does not represent a sale by the Reporting Person. Read SEC document |
| January 14, 2022 Filed Jan 19, 2022 21:43 UTC |
Aldag Edward K JRDirector · Chairman, President & CEO
|
GrantCommon stock, par value $0.001 | 154,780 | $0.00 | $0.00 |
DisclosureSEC source: 0001287865-22-000001 · primary_doc.xml · nonDerivative · entry 2 Aldag Edward K JR · CIK 0001331608 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,184,756 F2 · shares: Represents additional shares earned under the 2021 performance award based on the Company's actual performance as compared to the performance hurdles defined in the award agreement, adjusted pursuant to the modifier provisions in the award that were based on the Company's total return to shareholders. The shares vested in January 2022. Read SEC document |
| January 14, 2022 Filed Jan 19, 2022 21:43 UTC |
Aldag Edward K JRDirector · Chairman, President & CEO
|
GrantCommon stock, par value $0.001 | 778,809 | $0.00 | $0.00 |
DisclosureSEC source: 0001287865-22-000001 · primary_doc.xml · nonDerivative · entry 1 Aldag Edward K JR · CIK 0001331608 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,029,976 F1 · shares: Represents shares earned under the 2019 performance award based on the Company's actual performance as compared to the performance hurdles defined in the award agreement along with shares earned pursuant to the modifier provisions in the award, which allowed for more shares to be earned based on how the Company's relative total return to shareholders compared to the SNL Healthcare REIT Index. The shares vested in January 2022. Read SEC document |
| January 14, 2022 Filed Feb 13, 2023 19:01 UTC |
Pitman Elizabeth NDirector
|
OtherCommon stock, par value $0.001 | 217 | $23.83 | $5,171.11 |
DisclosureSEC source: 0001287865-23-000016 · primary_doc.xml · nonDerivative · entry 10 Pitman Elizabeth N · CIK 0001732148 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,309 F1 · shares: Pertains to de minimis dividend reinvestment transactions. Read SEC document |
| January 13, 2022 Filed Feb 13, 2023 19:01 UTC |
Pitman Elizabeth NDirector
|
OtherCommon stock, par value $0.001 | 40 | $23.72 | $948.80 |
DisclosureSEC source: 0001287865-23-000016 · primary_doc.xml · nonDerivative · entry 9 Pitman Elizabeth N · CIK 0001732148 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,092 F1 · shares: Pertains to de minimis dividend reinvestment transactions. Read SEC document |
| October 14, 2021 Filed Feb 13, 2023 19:01 UTC |
Pitman Elizabeth NDirector
|
OtherCommon stock, par value $0.001 | 46 | $20.53 | $944.38 |
DisclosureSEC source: 0001287865-23-000016 · primary_doc.xml · nonDerivative · entry 8 Pitman Elizabeth N · CIK 0001732148 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,052 F1 · shares: Pertains to de minimis dividend reinvestment transactions. Read SEC document |
| August 02, 2021 Filed Aug 3, 2021 21:06 UTC |
Stewart Michael GDirector
|
SaleCommon stock, par value $0.001 | 4,800 | $20.88 | $100,224.00 |
DisclosureSEC source: 0001287865-21-000019 · primary_doc.xml · nonDerivative · entry 1 Stewart Michael G · CIK 0001331453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 214,884 Read SEC document |
| July 08, 2021 Filed Feb 13, 2023 19:01 UTC |
Pitman Elizabeth NDirector
|
OtherCommon stock, par value $0.001 | 46 | $20.14 | $926.44 |
DisclosureSEC source: 0001287865-23-000016 · primary_doc.xml · nonDerivative · entry 7 Pitman Elizabeth N · CIK 0001732148 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,006 F1 · shares: Pertains to de minimis dividend reinvestment transactions. Read SEC document |
| June 30, 2021 Filed Jul 1, 2021 22:11 UTC |
Hanna James KevinVP, Controller & CAO
|
GrantCommon stock, par value $0.001 | 7,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001287865-21-000018 · primary_doc.xml · nonDerivative · entry 2 Hanna James Kevin · CIK 0001665881 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,429 F2 · shares: Shares will be earned based on the achievement of specific performance thresholds pertaining to the Company's per share funds from operations, EBITDA, and acquisitions, as defined and set by our compensation committee, over the period from January 1, 2021 through December 31, 2023, with the opportunity to earn up to one third of the award for 2021 performance against the specified measures. The actual number of shares to be issued will vary depending upon the achievement of specific performance thresholds. Read SEC document |
| June 30, 2021 Filed Jul 1, 2021 22:11 UTC |
Hanna James KevinVP, Controller & CAO
|
GrantCommon stock, par value $0.001 | 14,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001287865-21-000018 · primary_doc.xml · nonDerivative · entry 1 Hanna James Kevin · CIK 0001665881 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,179 F1 · shares: Shares vest at the beginning of each calendar quarter ending January 1, 2024. Read SEC document |
| April 08, 2021 Filed Feb 13, 2023 19:01 UTC |
Pitman Elizabeth NDirector
|
OtherCommon stock, par value $0.001 | 41 | $21.94 | $899.54 |
DisclosureSEC source: 0001287865-23-000016 · primary_doc.xml · nonDerivative · entry 6 Pitman Elizabeth N · CIK 0001732148 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,960 F1 · shares: Pertains to de minimis dividend reinvestment transactions. Read SEC document |
| March 30, 2021 Filed Mar 31, 2021 20:22 UTC |
Aldag Edward K JRDirector · Chairman, President & CEO
|
SaleCommon stock, par value $0.001 | 710,000 | $21.21 | $15,059,100.00 |
DisclosureSEC source: 0001287865-21-000017 · primary_doc.xml · nonDerivative · entry 1 Aldag Edward K JR · CIK 0001331608 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,251,167 F1 · price: This transaction was executed in multiple trades at prices ranging from $21.03 to $21.32. The price reported above reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 17, 2021 Filed Mar 18, 2021 20:43 UTC |
Hanna James KevinVP, Controller & CAO
|
SaleCommon stock, par value $0.001 | 33,000 | $21.32 | $703,560.00 |
DisclosureSEC source: 0001287865-21-000016 · primary_doc.xml · nonDerivative · entry 1 Hanna James Kevin · CIK 0001665881 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,679 F1 · price: This transaction was executed in multiple trades at prices ranging from $21.29 to $21.35. The price reported above reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 24, 2021 Filed Feb 25, 2021 23:10 UTC |
HAMNER R STEVENDirector · Executive Vice President & CFO
|
SaleCommon stock, par value $0.001 | 250,000 | $22.49 | $5,622,500.00 |
DisclosureSEC source: 0001287865-21-000015 · primary_doc.xml · nonDerivative · entry 1 HAMNER R STEVEN · CIK 0001067414 · Director · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,792,688 Read SEC document |
| February 09, 2021 Filed Feb 11, 2022 22:03 UTC |
THOMPSON C REYNOLDS IIIDirector
|
GiftCommon stock, par value $0.001 | 1,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001287865-22-000014 · primary_doc.xml · nonDerivative · entry 1 THOMPSON C REYNOLDS III · CIK 0001188038 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,026 Read SEC document |
| January 20, 2021 Filed Jan 21, 2021 16:45 UTC |
DAWSON G STEVENDirector
|
GrantCommon stock, par value $0.001 | 5,928 | $0.00 | $0.00 |
DisclosureSEC source: 0001287865-21-000006 · primary_doc.xml · nonDerivative · entry 1 DAWSON G STEVEN · CIK 0001020944 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,971 F1 · shares: Shares vest ratably at the beginning of each of the 12 calendar quarters beginning April 1, 2021. Read SEC document |
| January 20, 2021 Filed Jan 21, 2021 17:17 UTC |
Mozingo Caterina ArdonDirector
|
GrantCommon stock, par value $0.001 | 5,928 | $0.00 | $0.00 |
DisclosureSEC source: 0001287865-21-000009 · primary_doc.xml · nonDerivative · entry 1 Mozingo Caterina Ardon · CIK 0001804387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,169 F1 · shares: Shares vest ratably at the beginning of each of the 12 calendar quarters beginning April 1, 2021. Read SEC document |
| January 20, 2021 Filed Jan 21, 2021 17:29 UTC |
Pitman Elizabeth NDirector
|
GrantCommon stock, par value $0.001 | 5,928 | $0.00 | $0.00 |
DisclosureSEC source: 0001287865-21-000010 · primary_doc.xml · nonDerivative · entry 1 Pitman Elizabeth N · CIK 0001732148 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,150 F1 · shares: Shares vest ratably at the beginning of each of the 12 calendar quarters beginning April 1, 2021. Read SEC document |
| January 20, 2021 Filed Jan 21, 2021 22:01 UTC |
SPARKS DANIEL PAULDirector
|
GrantCommon stock, par value $0.001 | 5,928 | $0.00 | $0.00 |
DisclosureSEC source: 0001287865-21-000008 · primary_doc.xml · nonDerivative · entry 1 SPARKS DANIEL PAUL · CIK 0001619358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,247 F1 · shares: Shares vest ratably at the beginning of each of the 12 calendar quarters beginning April 1, 2021. Read SEC document |
| January 20, 2021 Filed Jan 21, 2021 21:55 UTC |
THOMPSON C REYNOLDS IIIDirector
|
GrantCommon stock, par value $0.001 | 5,928 | $0.00 | $0.00 |
DisclosureSEC source: 0001287865-21-000007 · primary_doc.xml · nonDerivative · entry 1 THOMPSON C REYNOLDS III · CIK 0001188038 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,731 F1 · shares: Shares vest ratably at the beginning of each of the 12 calendar quarters beginning April 1, 2021. Read SEC document |
| January 20, 2021 Filed Jan 21, 2021 21:37 UTC |
Stewart Michael GDirector
|
GrantCommon stock, par value $0.001 | 5,928 | $0.00 | $0.00 |
DisclosureSEC source: 0001287865-21-000005 · primary_doc.xml · nonDerivative · entry 1 Stewart Michael G · CIK 0001331453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,684 F1 · shares: Shares vest ratably at the beginning of each of the 12 calendar quarters beginning April 1, 2021. Read SEC document |
| January 15, 2021 Filed Jan 21, 2021 01:11 UTC |
HAMNER R STEVENDirector · Executive Vice President & CFO
|
ConversionRestricted common stock units · Derivative | 55,905 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001287865-21-000003 · primary_doc.xml · derivative · entry 6 HAMNER R STEVEN · CIK 0001067414 · Director · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock, par value $0.001 · 55,905 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: Represents shares earned under the 2018 performance award equal to approximately one third of the target number of shares granted. F6 · derivative.exercise_date: The shares vested on January 1, 2021. F6 · derivative.expiration_date: The shares vested on January 1, 2021. Read SEC document |
| January 15, 2021 Filed Jan 21, 2021 01:11 UTC |
HAMNER R STEVENDirector · Executive Vice President & CFO
|
GrantCommon stock, par value $0.001 | 93,526 | $0.00 | $0.00 |
DisclosureSEC source: 0001287865-21-000003 · primary_doc.xml · nonDerivative · entry 5 HAMNER R STEVEN · CIK 0001067414 · Director · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,139,888 F5 · shares: Represents additional shares earned under the 2018 performance award based on the Company's actual performance as compared to the performance hurdles defined in the award agreement along with shares earned pursuant to the modifier provisions in the award, which allowed for more shares to be earned based on how the Company's relative total return to shareholders compared to the SNL Healthcare REIT Index. The shares vested on January 1, 2021. Read SEC document |
| January 15, 2021 Filed Jan 21, 2021 01:11 UTC |
HAMNER R STEVENDirector · Executive Vice President & CFO
|
ConversionCommon stock, par value $0.001 | 55,905 | $0.00 | $0.00 |
DisclosureSEC source: 0001287865-21-000003 · primary_doc.xml · nonDerivative · entry 4 HAMNER R STEVEN · CIK 0001067414 · Director · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,046,362 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: Represents shares earned under the 2018 performance award equal to approximately one third of the target number of shares granted. Read SEC document |
| January 15, 2021 Filed Jan 21, 2021 01:11 UTC |
HAMNER R STEVENDirector · Executive Vice President & CFO
|
GrantCommon stock, par value $0.001 | 86,469 | $0.00 | $0.00 |
DisclosureSEC source: 0001287865-21-000003 · primary_doc.xml · nonDerivative · entry 3 HAMNER R STEVEN · CIK 0001067414 · Director · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,990,457 F3 · shares: Represents additional shares earned under the 2020 performance award based on the Company's actual performance as compared to the performance hurdles defined in the award agreement along with shares earned pursuant to the modifier provisions in the award, which allowed for more shares to be earned based on the Company's total return to shareholders and how the Company's relative total return to shareholders compared to the SNL Healthcare REIT Index. The shares vested on January 1, 2021. Read SEC document |
| January 15, 2021 Filed Jan 21, 2021 01:11 UTC |
HAMNER R STEVENDirector · Executive Vice President & CFO
|
GrantCommon stock, par value $0.001 | 196,785 | $0.00 | $0.00 |
DisclosureSEC source: 0001287865-21-000003 · primary_doc.xml · nonDerivative · entry 2 HAMNER R STEVEN · CIK 0001067414 · Director · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,903,988 F2 · shares: Shares will be earned based on the achievement of specific performance thresholds pertaining to the Company's per share funds from operations, EBITDA, and acquisitions, as defined and set by our compensation committee, over the period from January 1, 2021 through December 31, 2023, with the opportunity to earn up to one third of the award for 2021 performance against the specified measures. The actual number of shares to be issued will vary depending upon the achievement of specific performance thresholds. Read SEC document |
| January 15, 2021 Filed Jan 21, 2021 01:11 UTC |
HAMNER R STEVENDirector · Executive Vice President & CFO
|
GrantCommon stock, par value $0.001 | 101,374 | $0.00 | $0.00 |
DisclosureSEC source: 0001287865-21-000003 · primary_doc.xml · nonDerivative · entry 1 HAMNER R STEVEN · CIK 0001067414 · Director · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,707,203 F1 · shares: Shares vest ratably at the beginning of each of the 12 calendar quarters beginning April 1, 2021. Read SEC document |
| January 15, 2021 Filed Jan 21, 2021 01:32 UTC |
Hanna James KevinVP, Controller & CAO
|
ConversionRestricted common stock units · Derivative | 2,192 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001287865-21-000004 · primary_doc.xml · derivative · entry 4 Hanna James Kevin · CIK 0001665881 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock, par value $0.001 · 2,192 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents shares earned under the 2018 performance award equal to approximately one third of the target number of shares granted. F4 · derivative.exercise_date: The shares vested on January 1, 2021. F4 · derivative.expiration_date: The shares vested on January 1, 2021. Read SEC document |
| January 15, 2021 Filed Jan 21, 2021 01:32 UTC |
Hanna James KevinVP, Controller & CAO
|
GrantCommon stock, par value $0.001 | 2,497 | $0.00 | $0.00 |
DisclosureSEC source: 0001287865-21-000004 · primary_doc.xml · nonDerivative · entry 3 Hanna James Kevin · CIK 0001665881 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,679 F3 · shares: Represents additional shares earned under the 2018 performance award based on the Company's actual performance as compared to the performance hurdles defined in the award agreement. The shares vested on January 1, 2021. Read SEC document |
| January 15, 2021 Filed Jan 21, 2021 01:32 UTC |
Hanna James KevinVP, Controller & CAO
|
ConversionCommon stock, par value $0.001 | 2,192 | $0.00 | $0.00 |
DisclosureSEC source: 0001287865-21-000004 · primary_doc.xml · nonDerivative · entry 2 Hanna James Kevin · CIK 0001665881 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,182 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents shares earned under the 2018 performance award equal to approximately one third of the target number of shares granted. Read SEC document |
| January 15, 2021 Filed Jan 21, 2021 01:32 UTC |
Hanna James KevinVP, Controller & CAO
|
GrantCommon stock, par value $0.001 | 1,834 | $0.00 | $0.00 |
DisclosureSEC source: 0001287865-21-000004 · primary_doc.xml · nonDerivative · entry 1 Hanna James Kevin · CIK 0001665881 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,990 F1 · shares: Represents additional shares earned under the 2020 performance award based on the Company's actual performance as compared to the performance hurdles defined in the award agreement. The shares vested on January 1, 2021. Read SEC document |
| January 15, 2021 Filed Jan 21, 2021 00:37 UTC |
Aldag Edward K JRDirector · Chairman, President & CEO
|
ConversionRestricted common stock units · Derivative | 111,814 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001287865-21-000002 · primary_doc.xml · derivative · entry 6 Aldag Edward K JR · CIK 0001331608 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock, par value $0.001 · 111,814 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: Represents shares earned under the 2018 performance award equal to approximately one third of the target number of shares granted. F6 · derivative.exercise_date: The shares vested on January 1, 2021. F6 · derivative.expiration_date: The shares vested on January 1, 2021. Read SEC document |
| January 15, 2021 Filed Jan 21, 2021 00:37 UTC |
Aldag Edward K JRDirector · Chairman, President & CEO
|
GrantCommon stock, par value $0.001 | 187,055 | $0.00 | $0.00 |
DisclosureSEC source: 0001287865-21-000002 · primary_doc.xml · nonDerivative · entry 5 Aldag Edward K JR · CIK 0001331608 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,052,897 F5 · shares: Represents additional shares earned under the 2018 performance award based on the Company's actual performance as compared to the performance hurdles defined in the award agreement along with shares earned pursuant to the modifier provisions in the award, which allowed for more shares to be earned based on how the Company's relative total return to shareholders compared to the SNL Healthcare REIT Index. The shares vested on January 1, 2021. Read SEC document |
| January 15, 2021 Filed Jan 21, 2021 00:37 UTC |
Aldag Edward K JRDirector · Chairman, President & CEO
|
ConversionCommon stock, par value $0.001 | 111,814 | $0.00 | $0.00 |
DisclosureSEC source: 0001287865-21-000002 · primary_doc.xml · nonDerivative · entry 4 Aldag Edward K JR · CIK 0001331608 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,865,842 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: Represents shares earned under the 2018 performance award equal to approximately one third of the target number of shares granted. Read SEC document |
| January 15, 2021 Filed Jan 21, 2021 00:37 UTC |
Aldag Edward K JRDirector · Chairman, President & CEO
|
GrantCommon stock, par value $0.001 | 172,932 | $0.00 | $0.00 |
DisclosureSEC source: 0001287865-21-000002 · primary_doc.xml · nonDerivative · entry 3 Aldag Edward K JR · CIK 0001331608 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,754,028 F3 · shares: Represents additional shares earned under the 2020 performance award based on the Company's actual performance as compared to the performance hurdles defined in the award agreement along with shares earned pursuant to the modifier provisions in the award, which allowed for more shares to be earned based on the Company's total return to shareholders and how the Company's relative total return to shareholders compared to the SNL Healthcare REIT Index. The shares vested on January 1, 2021. Read SEC document |
| January 15, 2021 Filed Jan 21, 2021 00:37 UTC |
Aldag Edward K JRDirector · Chairman, President & CEO
|
GrantCommon stock, par value $0.001 | 393,570 | $0.00 | $0.00 |
DisclosureSEC source: 0001287865-21-000002 · primary_doc.xml · nonDerivative · entry 2 Aldag Edward K JR · CIK 0001331608 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,581,096 F2 · shares: Shares will be earned based on the achievement of specific performance thresholds pertaining to the Company's per share funds from operations, EBITDA, and acquisitions, as defined and set by our compensation committee, over the period from January 1, 2021 through December 31, 2023, with the opportunity to earn up to one third of the award for 2021 performance against the specified measures. The actual number of shares to be issued will vary depending upon the achievement of specific performance thresholds. Read SEC document |
| January 15, 2021 Filed Jan 21, 2021 00:37 UTC |
Aldag Edward K JRDirector · Chairman, President & CEO
|
GrantCommon stock, par value $0.001 | 202,748 | $0.00 | $0.00 |
DisclosureSEC source: 0001287865-21-000002 · primary_doc.xml · nonDerivative · entry 1 Aldag Edward K JR · CIK 0001331608 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,187,526 F1 · shares: Shares vest ratably at the beginning of each of the 12 calendar quarters beginning April 1, 2021. Read SEC document |
| January 15, 2021 Filed Jan 20, 2021 23:31 UTC |
McLean Emmett EExecutive Vice President & COO
|
ConversionRestricted common stock units · Derivative | 50,315 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001287865-21-000001 · primary_doc.xml · derivative · entry 6 McLean Emmett E · CIK 0001331446 · Executive Vice President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock, par value $0.001 · 50,315 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: Represents shares earned under the 2018 performance award equal to approximately one third of the target number of shares granted. F6 · derivative.exercise_date: The shares vested on January 1, 2021. F6 · derivative.expiration_date: The shares vested on January 1, 2021. Read SEC document |
| January 15, 2021 Filed Jan 20, 2021 23:31 UTC |
McLean Emmett EExecutive Vice President & COO
|
GrantCommon stock, par value $0.001 | 84,171 | $0.00 | $0.00 |
DisclosureSEC source: 0001287865-21-000001 · primary_doc.xml · nonDerivative · entry 5 McLean Emmett E · CIK 0001331446 · Executive Vice President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,665,695 F5 · shares: Represents additional shares earned under the 2018 performance award based on the Company's actual performance as compared to the performance hurdles defined in the award agreement along with shares earned pursuant to the modifier provisions in the award, which allowed for more shares to be earned based on how the Company's relative total return to shareholders compared to the SNL Healthcare REIT Index. The shares vested on January 1, 2021. Read SEC document |
| January 15, 2021 Filed Jan 20, 2021 23:31 UTC |
McLean Emmett EExecutive Vice President & COO
|
ConversionCommon stock, par value $0.001 | 50,315 | $0.00 | $0.00 |
DisclosureSEC source: 0001287865-21-000001 · primary_doc.xml · nonDerivative · entry 4 McLean Emmett E · CIK 0001331446 · Executive Vice President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,581,524 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: Represents shares earned under the 2018 performance award equal to approximately one third of the target number of shares granted. Read SEC document |
| January 15, 2021 Filed Jan 20, 2021 23:31 UTC |
McLean Emmett EExecutive Vice President & COO
|
GrantCommon stock, par value $0.001 | 64,980 | $0.00 | $0.00 |
DisclosureSEC source: 0001287865-21-000001 · primary_doc.xml · nonDerivative · entry 3 McLean Emmett E · CIK 0001331446 · Executive Vice President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,531,209 F3 · shares: Represents additional shares earned under the 2020 performance award based on the Company's actual performance as compared to the performance hurdles defined in the award agreement along with shares earned pursuant to the modifier provisions in the award, which allowed for more shares to be earned based on how the Company's relative total return to shareholders compared to the SNL Healthcare REIT Index. The shares vested on January 1, 2021. Read SEC document |
| January 15, 2021 Filed Jan 20, 2021 23:31 UTC |
McLean Emmett EExecutive Vice President & COO
|
GrantCommon stock, par value $0.001 | 124,034 | $0.00 | $0.00 |
DisclosureSEC source: 0001287865-21-000001 · primary_doc.xml · nonDerivative · entry 2 McLean Emmett E · CIK 0001331446 · Executive Vice President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,466,229 F2 · shares: Shares will be earned based on the achievement of specific performance thresholds pertaining to the Company's per share funds from operations, EBITDA, and acquisitions, as defined and set by our compensation committee, over the period from January 1, 2021 through December 31, 2023, with the opportunity to earn up to one third of the award for 2021 performance against the specified measures. The actual number of shares to be issued will vary depending upon the achievement of specific performance thresholds. Read SEC document |
| January 15, 2021 Filed Jan 20, 2021 23:31 UTC |
McLean Emmett EExecutive Vice President & COO
|
GrantCommon stock, par value $0.001 | 62,017 | $0.00 | $0.00 |
DisclosureSEC source: 0001287865-21-000001 · primary_doc.xml · nonDerivative · entry 1 McLean Emmett E · CIK 0001331446 · Executive Vice President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,342,195 F1 · shares: Shares vest ratably at the beginning of each of the 12 calendar quarters beginning April 1, 2021. Read SEC document |
| January 07, 2021 Filed Feb 13, 2023 19:01 UTC |
Pitman Elizabeth NDirector
|
OtherCommon stock, par value $0.001 | 43 | $20.10 | $864.30 |
DisclosureSEC source: 0001287865-23-000016 · primary_doc.xml · nonDerivative · entry 5 Pitman Elizabeth N · CIK 0001732148 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,919 F1 · shares: Pertains to de minimis dividend reinvestment transactions. Read SEC document |
| December 28, 2020 Filed Feb 12, 2021 22:32 UTC |
HAMNER R STEVENDirector · Executive Vice President & CFO
|
GiftLTIP Units · Derivative | 125,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001287865-21-000011 · primary_doc.xml · derivative · entry 4 HAMNER R STEVEN · CIK 0001067414 · Director · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock, par value $0.001 · 125,000 shares Expires not disclosed F1 · security: The LTIP units were converted into LP units in connection with the transfer pursuant to the terms of the Operating Partnership's limited partnership agreement. F1 · derivative.exercise_price: The LTIP units were converted into LP units in connection with the transfer pursuant to the terms of the Operating Partnership's limited partnership agreement. F1 · derivative.exercise_date: The LTIP units were converted into LP units in connection with the transfer pursuant to the terms of the Operating Partnership's limited partnership agreement. F1 · derivative.expiration_date: The LTIP units were converted into LP units in connection with the transfer pursuant to the terms of the Operating Partnership's limited partnership agreement. Read SEC document |
| December 28, 2020 Filed Feb 12, 2021 23:58 UTC |
McLean Emmett EExecutive Vice President & COO
|
GiftLTIP Units · Derivative | 107,142 | $0.00 | $0.00 |
DisclosureSEC source: 0001287865-21-000014 · primary_doc.xml · derivative · entry 1 McLean Emmett E · CIK 0001331446 · Executive Vice President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock, par value $0.001 · 107,142 shares Expires not disclosed F1 · security: The LTIP units were converted into LP units in connection with the transfer pursuant to the terms of the Operating Partnership's limited partnership agreement. F1 · derivative.exercise_price: The LTIP units were converted into LP units in connection with the transfer pursuant to the terms of the Operating Partnership's limited partnership agreement. F1 · derivative.exercise_date: The LTIP units were converted into LP units in connection with the transfer pursuant to the terms of the Operating Partnership's limited partnership agreement. F1 · derivative.expiration_date: The LTIP units were converted into LP units in connection with the transfer pursuant to the terms of the Operating Partnership's limited partnership agreement. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.